Neuromuscular Disorders
Clinical research in myasthenia gravis focuses on treatment strategies for autoimmune weakness and fatigability, with interest in therapies that modify disease activity and improve functional outcomes.
- Seropositive myasthenia gravis
- Immunomodulatory treatment
- Neuromuscular symptom control
The sponsor is active in therapeutic evaluation for chronic autoimmune neuromuscular disease, reflecting engagement with conditions requiring long-term clinical management.
Gynecologic Oncology
Research activity includes ovarian cancer and related fallopian tube cancer and peritoneal carcinoma, with attention to systemic treatment options used in advanced gynecologic malignancies.
- Ovarian cancer
- Fallopian tube cancer
- Peritoneal carcinoma
These studies place emphasis on treatment optimization in gynecologic oncology, particularly in diseases where disease control and progression management are central clinical concerns.
Vulvar Dermatology
Another area of interest is vulvar lichen sclerosus, including care in pediatric patients, where research addresses inflammatory skin and mucosal disease affecting the vulval region.
- Lichen sclerosus of the vulva
- Pediatric vulvar disease
- Topical anti-inflammatory therapy
Work in this field also considers the clinical relevance of dermatologic and mucosal inflammation in younger populations.
Immunology and Host Response
The sponsor’s studies include evaluation of immunologic, microbiologic, and genetic factors linked to treatment response, with particular attention to gut microbiota and vulvar microbiota.
- Immune response profiling
- Microbiome-related factors
- Genetic influences on therapy response
This research area connects host biology with clinical outcomes in inflammatory and oncologic conditions.
